June 15 Ovid Therapeutics Inc
* Ovid therapeutics - duncan's appointment filled vacancy on board created by board's increase in authorized size of board on june 14 from 5 members to 6 members
* Ovid therapeutics inc - appointed barbara duncan as a class i director Source text for Eikon: (bit.ly/2t7zNU0) Further company coverage:
Allianz expects loss of around $224 million from sale of OLB
FRANKFURT, June 25 German insurer Allianz expects to book a loss of around 200 million euros ($224 million) from the sale of private bank Oldenburgische Landesbank to U.S. private equity firm Apollo, it said on Sunday.
BRIEF-Vapiano SE determines number of shares for capital increase
* Vapiano SE determines number of shares for capital increase